Preservation of extremities in patients with occlussive peripheral artery disease

Authors

  • David Ortiz Limonta Hospital Provincial Docente Clinicoquirúrgico “Saturnino Lora Torres”, Universidad de Ciencias Médicas, Santiago de Cuba, Cuba.
  • David Ortiz Guilarte Facultad de Medicina No. 1, Universidad de Ciencias Médicas, Santiago de Cuba, Cuba.

Keywords:

occlussive peripheral artery disease, critical ischemic obliterating atherosclerosis of the extremity, prostaglandin E1

Abstract

The case report of 2 patients with occlussive peripheral artery disease due to obliterating atherosclerosis type 3, stage IV, with critical ischemia of the extremities who were assisted in the Hospital of the Ecuadorian Social Security Institute of Ibarra, Imbabura province, Republic of Ecuador through the agreement with the Cuban medical services, are described. The affected patients were treated with alprostadil via parenteral, in order to alleviate pain during rest, to achieve the scaring of the ulcers, to limit the ischemic gangrene and to carry out just smaller amputations, so that the affected  patients preserved their extremities and they returned to their daily activities.  

Downloads

Download data is not yet available.

References

1. Cuevas R B, Fonseca LJL, Hermida FG. La terapia celular en el tratamiento de la isquemia critica de extremidades inferiores. Rev Electron Biomed.2006;2:65-71.

2. Guindo J, Martínez RMD, Gusi G. Métodos diagnóstico de la enfermedad arterial periférica. Importancia del índice tobillo – brazo como técnica de criba. Rev Española Cardiol. 2009;9(4):11-7.

3. Brass EP, Koster D, Hiatt WR, Amato A. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication. Vasc Med. 2013;18(1):3-12.

4. Backer TL de, Vander Stichele R. Buflomedil for intermittent claudication. Cochrane Database Syst Rev. 2013 [citado 15 Ago 2015];28(3). Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23543509

5. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Goto S, et al. On behalf of the REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J. 2014;35(41):2864-72.

6. Westin GG, Armstrong EJ, Bang H, Yeo KK, Anderson D, Dawson DL, et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol. 2014;63(7):682-90.

7. Warner CJ, Greaves SW, Larson RJ, Stone DH, Powell RJ, Walsh DB, et al. Cilosta

Downloads

Published

2016-02-06

How to Cite

1.
Ortiz Limonta D, Ortiz Guilarte D. Preservation of extremities in patients with occlussive peripheral artery disease. MEDISAN [Internet]. 2016 Feb. 6 [cited 2025 Jun. 22];20(2). Available from: https://medisan.sld.cu/index.php/san/article/view/686

Issue

Vol. 20 No. 2 (2016): MEDISAN

Section

Case Reports

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.